Post-Cesarean Opioid Use after Implementation of Enhanced Recovery after Surgery Protocol.
| Autor: | MacGregor CA; Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois.; Department of Obstetrics and Gynecology, University of Chicago Pritzker School of Medicine, Chicago, Illinois., Neerhof M; Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois., Sperling MJ; Care Transformation, NorthShore University HealthSystem, Evanston, Illinois., Alspach D; Department of Anesthesiology, NorthShore University HealthSystem, Evanston, Illinois., Plunkett BA; Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois., Choi A; Department of Obstetrics and Gynecology, NorthShore University HealthSystem, Evanston, Illinois., Blumenthal R; Department of Anesthesiology, NorthShore University HealthSystem, Evanston, Illinois. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of perinatology [Am J Perinatol] 2021 Jun; Vol. 38 (7), pp. 637-642. Date of Electronic Publication: 2020 Dec 02. |
| DOI: | 10.1055/s-0040-1721075 |
| Abstrakt: | Objective: This study aimed to evaluate whether implementation of an enhanced recovery after surgery (ERAS) protocol is associated with lower maternal opioid use after cesarean delivery (CD). Study Design: We performed a pre- and postimplementation (PRE and POST, respectively) study of an ERAS protocol for cesarean deliveries. ERAS is a multimodal, multidisciplinary perioperative approach. The four pillars of our protocol include education, pain management, nutrition, and early ambulation. Patients were counseled by their outpatient providers and given an educational booklet. Pain management included gabapentin and acetaminophen immediately prior to spinal anesthesia. Postoperatively patients received scheduled acetaminophen and ibuprofen. Oxycodone was initiated as needed 24 hours after spinal analgesia. Preoperative diet consisted of clear carbohydrate drink consumed 2 hours prior to scheduled operative time with advancement as tolerated immediately postoperation. Women with a body mass index (BMI) <40 kg/m 2 and scheduled CD were eligible for ERAS. PRE patients were randomly selected from repeat cesarean deliveries (RCDs) at a single site from October 2017 to September 2018, BMI <40 kg/m 2 , without trial of labor. The POST cohort included women who participated in ERAS from October 2018 to June 2019. PRE and POST demographic and clinical characteristics were compared. Primary outcome was total postoperative morphine milligram equivalents (MMEs). Secondary outcomes included length of stay (LOS) and maximum postoperative day 2 (POD2) pain score. Results: All women in PRE ( n = 70) had RCD compared with 66.2% (49/74) in POST. Median total postoperative MMEs were 140.0 (interquartile range [IQR]: 87.5-182.5) in PRE compared with 0.0 (IQR: 0.0-72.5) in POST ( p < 0.001). Median LOS in PRE was 4.02 days (IQR: 3.26-4.27) compared with 2.37 days (IQR: 2.21-3.26) in POST ( p < 0.001). Mean maximum POD2 pain score was 5.28 (standard deviation [SD] = 1.86) in PRE compared with 4.67 (SD = 1.63) in POST ( p = 0.04). Conclusion: ERAS protocol was associated with decreased postoperative opioid use, shorter LOS, and decreased pain after CD. Key Points: · ERAS protocol was associated with decreased postoperative opioid use after CD.. · ERAS protocol was associated with shorter length of stay after CD.. · ERAS protocol was associated with decreased postoperative pain after CD.. Competing Interests: None declared. (Thieme. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|